MedTrace Logo

A Retrospective Study to Determine the Incidence of NTRK Fusions. NTRK Study

NCT04010240 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3820

Last updated 2025-10-16

Study results available
· View outcomes & findings →

Summary

This retrospective study has a primary objective to estimate the incidence of NTRK gene fusion depending on the histological diagnosis.

Conditions

  • Metastatic Solid Tumors

Interventions

OTHER

No intervention (this is a retrospective cohort study)

No intervention (this is a retrospective cohort study) aimed at describing tumour samples. No treatment/intervention is being tested.

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Institut Bergonié

    lead OTHER

Principal Investigators

Eligibility

Min Age
1 Month
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-12-23
Primary Completion
2022-12-31
Completion
2022-12-31

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04010240 on ClinicalTrials.gov